Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junxiao Ye

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2014
15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targetingJunxiao Ye, Meong Cheol Shin, Qiuling Liang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2014
Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptideHuining He, Junxiao Ye, Ergang Liu, et al.
Theranostics|July 27, 2017
High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNAJunxiao Ye, Ergang Liu, Junbo Gong, et al.
Asian-Australasian Journal of Animal Sciences|July 30, 2018
Gene expression and promoter methylation of porcine uncoupling protein 3 geneRuiyi Lin, Weimin Lin, Qiaohui Chen, et al.
Current Pharmaceutical Biotechnology|October 15, 2014
CPP mediated insulin delivery: current status and promising futureErgang Liu, Jianyong Sheng, Junxiao Ye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2022
Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancerLei Dou, Huiqin Liu, Kaixin Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2015
Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agentsHuining He, Lu Sun, Junxiao Ye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 12, 2022
Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Journal of Controlled Release 349 (2022) 876-889]Lei Dou, Huiqin Liu, Kaixin Wang, et al.
Journal of Materials Chemistry. B|April 9, 2020
Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancerSunhui Chen, Qiuling Liang, Ergang Liu, et al.
Acta Pharmaceutica Sinica. B|June 7, 2018
Improved method for synthesis of low molecular weight protamine-siRNA conjugateZhili Yu, Junxiao Ye, Xing Pei, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2014
15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targetingJunxiao Ye, Meong Cheol Shin, Qiuling Liang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2014
Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptideHuining He, Junxiao Ye, Ergang Liu, et al.
Theranostics|July 27, 2017
High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNAJunxiao Ye, Ergang Liu, Junbo Gong, et al.
Asian-Australasian Journal of Animal Sciences|July 30, 2018
Gene expression and promoter methylation of porcine uncoupling protein 3 geneRuiyi Lin, Weimin Lin, Qiaohui Chen, et al.
Current Pharmaceutical Biotechnology|October 15, 2014
CPP mediated insulin delivery: current status and promising futureErgang Liu, Jianyong Sheng, Junxiao Ye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2022
Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancerLei Dou, Huiqin Liu, Kaixin Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2015
Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agentsHuining He, Lu Sun, Junxiao Ye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 12, 2022
Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Journal of Controlled Release 349 (2022) 876-889]Lei Dou, Huiqin Liu, Kaixin Wang, et al.
Journal of Materials Chemistry. B|April 9, 2020
Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancerSunhui Chen, Qiuling Liang, Ergang Liu, et al.
Acta Pharmaceutica Sinica. B|June 7, 2018
Improved method for synthesis of low molecular weight protamine-siRNA conjugateZhili Yu, Junxiao Ye, Xing Pei, et al.
Pageof 2